Assessment of evidence for a protective role of vitamin D in multiple sclerosis

by Hanwell H.E.C., Banwell B.
Biochimica et Biophysica Acta - Molecular Basis of Disease ()


Evidence for a role of vitamin D insufficiency in determining risk in Multiple Sclerosis (MS) is supported by studies in both pediatric- and adult-onset patients. The potential role of vitamin D in modulating MS disease activity is an area of active clinical trials research, and the possibility of primary disease prevention with vitamin D supplementation in early life is an emerging concept. With Sir Austin Bradford Hill's criteria as a framework, the present review assesses the evidence for a causal relationship between vitamin D insufficiency and the pathobiology of MS, and discusses rationale for future clinical trials with vitamin D. 2010 Elsevier B.V.

Cite this document (BETA)

Readership Statistics

2 Readers on Mendeley
by Discipline
by Academic Status
50% Librarian
50% Student (Master)
by Country
50% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in